|
1.Mills JJ JR, Boyer IJ: Mechanism of liver tumor promotion. In: Jirtle RL (ed) Liver regeneration and carcinogenesis. Academic Press, San Diego 1995:199–226.
2.Pitot HC, Campbell HA, Maronpot R, Bawa N, Rizvi TA, Xu YH, Sargent L, Dragan Y, Pyron M: Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol 1989;17:594-611; discussion 611-592.
3.Farber E, Sarma DS: Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987;56:4-22.
4.Pitot HC, Dragan YP: Facts and theories concerning the mechanisms of carcinogenesis. Faseb J 1991;5:2280-2286.
5.Peraino C, Staffeldt EF, Carnes BA, Ludeman VA, Blomquist JA, Vesselinovitch SD: Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res 1984;44:3340-3347.
6.Farber E: Clonal adaptation during carcinogenesis. Biochem Pharmacol 1990;39:1837-1846.
7.Solt D FE: New principle for analysis of chemical carcinogenesis. Nature 1976;263:701-703.
8.Ito N, Tsuda H, Tatematsu M, Inoue T, Tagawa Y, Aoki T, Uwagawa S, Kagawa M, Ogiso T, Masui T, et al.: Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats an approach for a new medium-term bioassay system. Carcinogenesis 1988;9:387-394.
9.Strange RC, Fryer AA: The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci Publ 1999:231-249.
10.Hayes JD, Strange RC: Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995;22:193-207.
11.Smith G, Stanley LA, Sim E, Strange RC, Wolf CR: Metabolic polymorphisms and cancer susceptibility. Cancer Surv 1995;25:27-65.
12.Zhang Y, Talalay P: Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 1994;54:1976s-1981s.
13.Puchalski RB, Fahl WE: Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents. Proc Natl Acad Sci U S A 1990;87:2443-2447.
14.Clapper ML, Hoffman SJ, Tew KD: Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1991;1096:209-216.
15.Clapper ML, Hoffman SJ, Carp N, Watts P, Seestaller LM, Weese JL, Tew KD: Contribution of patient history to the glutathione S-transferase activity of human lung, breast and colon tissue. Carcinogenesis 1991;12:1957-1961.
16.Chen HW, Yang JJ, Tsai CW, Wu JJ, Sheen LY, Ou CC, Lii CK: Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats. J Nutr 2001;131:1438-1443.
17.Katagiri A, Tomita Y, Nishiyama T, Kimura M, Sato S: Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer. Br J Cancer 1993;68:125-129.
18.Sato K, Kitahara A, Satoh K, Ishikawa T, Tatematsu M, Ito N: The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. Gann 1984;75:199-202.
19.Cameron RG: Identification of the putative first cellular step of chemical hepatocarcinogenesis. Cancer Lett 1989;47:163-167.
20.Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K: Single GST-P positive liver cells putative initiated hepatocytes. Carcinogenesis 1987;8:483-486.
21.Satoh K, Hatayama I, Tateoka N, Tamai K, Shimizu T, Tatematsu M, Ito N, Sato K: Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 1989;10:2107-2111.
22.Dragan YP, Laufer C, Koleske AJ, Drinkwater N, Pitot HC: Quantitative comparison of initiation and mutation phenotypes in hepatocytes of the analbuminemic rat. Jpn J Cancer Res 1993;84:175-183.
23.Grasl-Kraupp B, Luebeck G, Wagner A, Low-Baselli A, de Gunst M, Waldhor T, Moolgavkar S, Schulte-Hermann R: Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis). Carcinogenesis 2000;21:1411-1421.
24.Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K: Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci U S A 1985;82:3964-3968.
25.Bravo R, Frank R, Blundell PA, Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-517.
26.Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 1986;166:209-219.
27.Galand P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989;22:383-392.
28.Wu PC, Lau VK, Fang JW, Lai VC, Lai CL, Lau JY: Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma. Liver 1999;19:444-451.
29.Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, et al.: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-294.
30.Suehiro T, Matsumata T, Itasaka H, Yamamoto K, Kawahara N, Sugimachi K: Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen. Cancer 1995;76:399-405.
31.Bringman TS, Lindquist PB, Derynck R: Different transforming growth factor-alpha species are derived from a glycosylated and palmitoylated transmembrane precursor. Cell 1987;48:429-440.
32.Massague J: Transforming growth factor-alpha. A model for membrane-anchored growth factors. J Biol Chem 1990;265:21393-21396.
33.Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-712.
34.Massague J: Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem 1983;258:13614-13620.
35.Mead JE, Fausto N: Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci U S A 1989;86:1558-1562.
36.Collier JD, Guo K, Gullick WJ, Bassendine MF, Burt AD: Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver 1993;13:151-155.
37.Laird AD, Brown PI, Fausto N: Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene. Cancer Res 1994;54:4224-4232.
38.Dragan Y, Teeguarden J, Campbell H, Hsia S, Pitot H: The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression. Cancer Lett 1995;93:73-83.
39.Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC: Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990;61:1121-1135.
40.Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990;61:1137-1146.
41.Johnson AC, Garfield SH, Merlino GT, Pastan I: Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liver. Biochem Biophys Res Commun 1988;150:412-418.
42.Ostrowski JL, Ingleton PM, Underwood JC, Parsons MA: Increased hepatic androgen receptor expression in female rats during diethylnitrosamine liver carcinogenesis. A possible correlation with liver tumor development. Gastroenterology 1988;94:1193-1200.
43.Srivastava RK, Gu Y, Ayloo S, Zilberstein M, Gibori G: Developmental expression and regulation of basic fibroblast growth factor and vascular endothelial growth factor in rat decidua and in a decidual cell line. J Mol Endocrinol 1998;21:355-362.
44.Brown PI, Lam R, Lakshmanan J, Fisher DA: Transforming growth factor alpha in developing rats. Am J Physiol 1990;259:E256-260.
45.Terada T, Ohta T, Nakanuma Y: Expression of transforming growth factor-alpha and its receptor during human liver development and maturation. Virchows Arch 1994;424:669-675.
46.Magee PN, Barnes JM: The production of malignant primary hepatic tumours in the rat by feeding dimethylnitrosamine. Br J Cancer 1956;10:114-122.
47.Shank RC: Toxicology of N-nitroso compounds. Toxicol Appl Pharmacol 1975;31:361-368.
48.Bartsch H, Montesano R: Relevance of nitrosamines to human cancer. Carcinogenesis 1984;5:1381-1393.
49.Bartsch H, Hietanen E, Malaveille C: Carcinogenic nitrosamines: free radical aspects of their action. Free Radic Biol Med 1989;7:637-644.
50.Verna L, Whysner J, Williams GM: N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 1996;71:57-81.
51.Halliwell B, Murcia MA, Chirico S, Aruoma OI: Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit Rev Food Sci Nutr 1995;35:7-20.
52.Scandalios JG: Oxygen Stress and Superoxide Dismutases. Plant Physiol 1993;101:7-12.
53.Fridovich I: The biology of oxygen radicals. Science 1978;201:875-880.
54.Liu SY, Wu WK, Wang JY, Son LM, Yen MH, Lin CC: Studies on the agronomic characteristics, yield, and saikosaponin content of two Bupleurum species in Taiwan. Am J Chin Med 1995;23:181-194.
55.Balendiran GK, Dabur R, Fraser D: The role of glutathione in cancer. Cell Biochem Funct 2004;22:343-352.
56.Sugiyama K, Izawa S, Inoue Y: The Yap1p-dependent induction of glutathione synthesis in heat shock response of Saccharomyces cerevisiae. J Biol Chem 2000;275:15535-15540.
57.Dragan YP, Hully J, Crow R, Mass M, Pitot HC: Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis. Carcinogenesis 1994;15:1939-1947.
58.Cohen SM, Ellwein LB: Cell proliferation in carcinogenesis. Science 1990;249:1007-1011.
59.Eldrige SR, Butterworth BE, Goldsworthy TL: Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. Environ Health Perspect 1993;101 Suppl 5:211-218.
60.Lin CC, Chiu HF, Yen MH, Wu CC, Chen MF: The pharmacological and pathological studies on Taiwan folk medicine (III): The effects of bupleurum kaoi and cultivated bupleurum falcatum var. komarowi. Am J Chin Med 1990;18:105-112.
61.Lin CC, Yen MH, Chen JY, Chuang CH, Namba T: Anatomical and histological studies of Bupleuri radix. Am J Chin Med 1991;19:265-274.
62.Matsuda H, Murakami, T, Ninomiya, K, Inadzuki, M, Yoshikawa, M: New hepatoprotective saponins, bupleurosides III,VI, IX, and XIII, from Chinese Bupleuri Radix: structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes. Bioorganic and Medicinal Chemistry Letters 1997;7:2193-2198.
63.Yen MH, Lin CC, Chuang CH, Liu SY: Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of "xiao-chai-hu-tang" prepared using three different Bupleurum species. J Ethnopharmacol 1991;34:155-165.
64.Yen MH, Lin CC, Chang CH, Lin SC: Anti-inflammatory and hepatoprotective activity of saikosaponin-f and the root extract of Bupleurum kaoi. . Fitoterapia 1994;65:409-417.
65.Wang BJ, Liu CT, Tseng CY, Wu CP, Yu ZR: Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO(2) on CCl(4)-induced liver damage. Food Chem Toxicol 2004;42:609-617.
66.Wang BJ, Liu CT, Tseng CT, Yu ZR: Fractionation using supercritical CO2 changes the antioxidant activity of Bupleurum kaoi Liu (Chao et Chuang). Food Science and Technology-Lebensmittel-Wissenschaft and Technologie (Submitted for publication). 2003.
67.Yen MH, Weng TC, Liu SY, Chai CY, Lin CC: The hepatoprotective effect of Bupleurum kaoi, an endemic plant to Taiwan, against dimethylnitrosamine-induced hepatic fibrosis in rats. Biol Pharm Bull 2005;28:442-448.
68.Hsu YL, Kuo PL, Weng TC, Yen MH, Chiang LC, Lin CC: The antiproliferative activity of saponin-enriched fraction from Bupleurum kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells. Biol Pharm Bull 2004;27:1112-1115.
69.Yamada H, Ra KS, Kiyohara H, Cyong JC, Otsuka Y: Structural characterization of an anti-complementary pectic polysaccharide from the roots of Bupleurum falcatum L. Carbohydr Res 1989;189:209-226.
70.Jia X, Han C, Chen J: Effects of tea on preneoplastic lesions and cell cycle regulators in rat liver. Cancer Epidemiol Biomarkers Prev 2002;11:1663-1667.
71.Greenwell A, Foley JF, Maronpot RR: An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 1991;59:251-256.
72.Beauchamp C, Fridovich I: Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-287.
73.Crapo JD, McCord JM: Oxygen-induced changes in pulmonary superoxide dismutase assayed by antibody titrations. Am J Physiol 1976;231:1196-1203.
74.Aebi H: Catalase in vitro. Methods Enzymol 1984;105:121-126.
75.Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
76.Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
77.Burr AW, Toole K, Mathew J, Hines JE, Chapman C, Burt AD: Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis. J Pathol 1996;179:276-282.
78.Kaufmann WK, Zhang Y, Kaufman DG: Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms. Carcinogenesis 1992;13:1481-1483.
79.Pitot HC, Goodspeed D, Dunn T, Hendrich S, Maronpot RR, Moran S: Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis. Toxicol Appl Pharmacol 1989;97:23-34.
80.Rajkapoor B, Murugesh N, Chodon D, Sakthisekaran D: Chemoprevention of N-nitrosodiethylamine induced phenobarbitol promoted liver tumors in rat by extract of Indigofera aspalathoides. Biol Pharm Bull 2005;28:364-366.
81.Sanchez-Perez Y, Carrasco-Legleu C, Garcia-Cuellar C, Perez-Carreon J, Hernandez-Garcia S, Salcido-Neyoy M, Aleman-Lazarini L, Villa-Trevino S: Oxidative stress in carcinogenesis. Correlation between lipid peroxidation and induction of preneoplastic lesions in rat hepatocarcinogenesis. Cancer Lett 2005;217:25-32.
82.Satoh K, Hatayama I, Tsuchida S, Sato K: Biochemical characteristics of a preneoplastic marker enzyme glutathione S-transferase P-form(7-7). Arch Biochem Biophys 1991;285:312-316.
83.Nishimori H, Tsukishiro T, Nambu S, Okada K, Shimizu Y, Miyabayashi C, Higuchi K, Watanabe A: Analyses of proliferating cell nuclear antigen-positive cells in hepatocellular carcinoma: comparisons with clinical findings. J Gastroenterol Hepatol 1994;9:425-432.
|